122 related articles for article (PubMed ID: 37562724)
1. Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individuals.
Ravalet N; Guermouche H; Hirsch P; Picou F; Foucault A; Gallay N; Martignoles JA; Beaud J; Suner L; Deswarte C; Lachot S; Rault E; Largeaud L; Gissot V; Béné MC; Gyan E; Delhommeau F; Herault O
Clin Immunol; 2023 Oct; 255():109730. PubMed ID: 37562724
[TBL] [Abstract][Full Text] [Related]
2. Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals.
Cluitmans FH; Esendam BH; Landegent JE; Willemze R; Falkenburg JH
Blood; 1995 Apr; 85(8):2038-44. PubMed ID: 7718876
[TBL] [Abstract][Full Text] [Related]
3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
4. Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.
Shahrivari M; Wise E; Resende M; Shuster JJ; Zhang J; Bolli R; Cooke JP; Hare JM; Henry TD; Khan A; Taylor DA; Traverse JH; Yang PC; Pepine CJ; Cogle CR;
Circ Res; 2017 Jun; 120(12):1947-1957. PubMed ID: 28490433
[TBL] [Abstract][Full Text] [Related]
5. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
Janowska-Wieczorek A; Marquez LA; Nabholtz JM; Cabuhat ML; Montaño J; Chang H; Rozmus J; Russell JA; Edwards DR; Turner AR
Blood; 1999 May; 93(10):3379-90. PubMed ID: 10233890
[TBL] [Abstract][Full Text] [Related]
6. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.
Prosper F; Vanoverbeke K; Stroncek D; Verfaillie CM
Blood; 1997 Jun; 89(11):3991-7. PubMed ID: 9166837
[TBL] [Abstract][Full Text] [Related]
7. The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo.
Quesniaux VF; Wehrli S; Steiner C; Joergensen J; Schuurman HJ; Herrman P; Schreier MH; Schuler W
Blood; 1994 Sep; 84(5):1543-52. PubMed ID: 7520778
[TBL] [Abstract][Full Text] [Related]
8. The role of cytokines and hematopoietic growth factors in the autocrine/paracrine regulation of inducible hematopoiesis.
Cluitmans FH; Esendam BH; Veenhof WF; Landegent JE; Willemze R; Falkenburg JH
Ann Hematol; 1997; 75(1-2):27-31. PubMed ID: 9322680
[TBL] [Abstract][Full Text] [Related]
9. Efflux of CD34+ cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration.
Steen R; Tjønnfjord GE; Gunnes Grøseth LA; Heldal D; Egeland T
J Hematother; 1997 Dec; 6(6):563-73. PubMed ID: 9483191
[TBL] [Abstract][Full Text] [Related]
10. Human CD34(+) bone marrow cells regulate stromal production of interleukin-6 and granulocyte colony-stimulating factor and increase the colony-stimulating activity of stroma.
Gupta P; Blazar BR; Gupta K; Verfaillie CM
Blood; 1998 May; 91(10):3724-33. PubMed ID: 9573009
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor (CSF) but not interleukin-1 (IL-1), IL-3, and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T cells.
Gerritsen WR; O'Reilly RJ
Blood; 1994 Sep; 84(6):1906-12. PubMed ID: 7521693
[TBL] [Abstract][Full Text] [Related]
13. Validity of Luminex and Enzyme-Linked Immunosorbent Assay Measuring Vascular Endothelial Growth Factor and Six Cytokines Quantitatively in Bone Marrow Aspiration Supernatant: Pilot Study.
Cho CH; Park MC
Ann Clin Lab Sci; 2022 Jul; 52(4):663-676. PubMed ID: 36197768
[TBL] [Abstract][Full Text] [Related]
14. Cytokine/Chemokine responses in activated CD4+ and CD8+ T cells isolated from peripheral blood, bone marrow, and axillary lymph nodes during acute simian immunodeficiency virus infection.
Kenway-Lynch CS; Das A; Lackner AA; Pahar B
J Virol; 2014 Aug; 88(16):9442-57. PubMed ID: 24920807
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic growth factors and glucocorticoids synergize to mimic the effects of IL-1 on granulocyte differentiation and IL-1 receptor induction on bone marrow cells in vivo.
Dubois CM; Neta R; Keller JR; Jacobsen SE; Oppenheim JJ; Ruscetti F
Exp Hematol; 1993 Feb; 21(2):303-10. PubMed ID: 7678814
[TBL] [Abstract][Full Text] [Related]
16. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
[TBL] [Abstract][Full Text] [Related]
17. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
[TBL] [Abstract][Full Text] [Related]
19. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells.
Aerts-Kaya F; Kilic E; Köse S; Aydin G; Cagnan I; Kuskonmaz B; Uckan-Cetinkaya D
Cytokine; 2021 Mar; 139():155407. PubMed ID: 33383380
[TBL] [Abstract][Full Text] [Related]
20. Regulatory effect of recombinant interleukin (IL)3 and IL4 on cytokine gene expression of bone marrow and peripheral blood mononuclear cells.
Brantschen S; Gauchat JF; De Weck AL; Stadler BM
Eur J Immunol; 1989 Nov; 19(11):2017-23. PubMed ID: 2480900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
